Numerous studies have demonstrated that the upregulation of METTL3, frequently observed in tumors, promotes tumor cell survival, proliferation, self-renewal, metastasis, and drug resistance by modulating mRNA metabolism3. This evidence concerns the gene METTL3 and neoplasm.